Betamox 250. Betamox 500. Betamox S. Betamox Sf 250 mg & 500 mg. 125 mg & 250 mg Capsules. Suspension
PDF Leaflet Revision Date: 12 March 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible organisms.
Dosage (summary)
Adults: 250 mg three times daily; adjust for renal impairment.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Limited data show no increased risk in pregnancy; excreted in breast milk.
Key Drug Interactions
- Probenecid
- Allopurinol
- Tetracyclines
- Oral anticoagulants
Contraindications
- Hypersensitivity to penicillins
- Infectious mononucleosis
- Lymphatic leukaemia
Common side effects
- Diarrhoea
- Nausea
- Skin rash
Counselling Points
- Take with or without food
- Report any allergic reactions
- Maintain hydration to prevent crystalluria
Serious warnings
- Serious hypersensitivity reactions
- Convulsions in renal impairment
Important Disclaimer
The Betamox 250. Betamox 500. Betamox S. Betamox Sf 250 mg & 500 mg. 125 mg & 250 mg Capsules. Suspension professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
